TBPH Theravance Biopharma Inc
1,032
$9.82
$0.43
(4.58%)
| Watchers | 1,032 |
| 52-Wk Low | $8.21 |
| 52-Wk High | $11.71 |
| Market Cap | $461.42M |
| Volume | 83,408.00 |
| 52-Wk High | $11.71 |
| 52-Wk Low | $8.21 |
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business UpdatePR Newswire • 2 days ago
Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update Theravance Biopharma, Inc. Reports First Quarter 2024 Financial Results and Provides Business...
Share to Feed
Theravance Biopharma to Participate in an Upcoming Investor Conference Theravance Biopharma to Participate in an Upcoming Investor Conference PR Newswire DUBLIN, May 9, 2024 DUBLIN, May 9, 2024...
Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024 Theravance Biopharma to Report First Quarter 2024 Financial Results on May 13, 2024 PR Newswire DUBLIN, April 29...
Theravance Biopharma, Inc. to Host Virtual Key Opinion Leader (KOL) Event to Discuss Ampreloxetine's Potential for the Treatment of Symptomatic Neurogenic Orthostatic Hypotension (nOH) in Patients...
This is a signal that TBPH's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This indicator may be signaling TBPH's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
This is a Bullish indicator signaling TBPH's price could rise from here. Traders may explore going long the stock or buying call options...
Theravance Biopharma, Inc. (NASDAQ:TBPH Free Report) Investment analysts at Zacks Research issued their FY2026 earnings estimates for shares of Theravance Biopharma in a note issued...
This is a Bearish indicator signaling TBPH's price could decline from here. Traders may explore shorting the stock or put options...